Pulse Biosciences Receives Upgrade to 'Sell' from StockNews.com

Pulse Biosciences (NASDAQ:PLSE) was recently assigned a "sell" rating by analysts from StockNews.com in a research note published on Monday.

Pulse Biosciences Stock Overview

On Monday, shares of Pulse Biosciences fell by $0.51, closing at $16.09. In total, 459,987 shares changed hands, surpassing the average trading volume of 198,258. The stock is currently trading below its fifty-day moving average of $18.78 and its two-hundred-day moving average of $18.15. Over the past year, Pulse Biosciences has experienced a low of $6.60 and a high of $25.00.

Institutional Investment Trends

Several hedge funds have recently altered their stake in Pulse Biosciences. Notably, Invesco Ltd. dramatically increased its position by 1,956.7% during the fourth quarter, now holding 214,490 shares valued at approximately $3,734,000 due to an additional purchase of 204,061 shares. Meanwhile, Vanguard Group Inc. raised its holdings by 15.1%, bringing their total to 1,146,339 shares valued at around $19,958,000 after acquiring an extra 150,506 shares. Charles Schwab Investment Management Inc. surged by 193.0% in the third quarter, amplifying its shareholding to 148,114 shares worth $2,598,000 with a recent purchase of 97,565 shares. State Street Corp also increased its stake by 17.8%, now owning 461,333 shares valued at $8,092,000 after buying 69,696 additional shares. Additionally, Panoramic Capital LLC made a new investment in Pulse Biosciences, valued at about $846,000 during the fourth quarter. Currently, institutional investors hold approximately 76.95% of the company's stock.

About Pulse Biosciences

Pulse Biosciences, Inc. is a pioneering bioelectric medicine company that specializes in non-invasive treatments through advanced technology. The company’s flagship product, the CellFX System, utilizes Nano-Pulse Stimulation to deliver precise electrical pulses capable of selectively targeting and treating various medical conditions while protecting surrounding healthy tissues.

Pulse, Biosciences, Stock, Upgrade, Sell